AIDS breakthough can neutralize HIV


Recommended Posts

(TIME.com) -- Researchers report a breakthrough in generating powerful antibodies that can neutralize HIV.

An HIV infection is really an intensive molecular arms race launched from the minute the virus infects a new host.

AIDS progresses not because the body isn't capable of fighting off HIV -- it is. But the immune defenses eventually succumb to the virus in the final standoff.

Now researchers led by Barton Haynes, director of the Duke University Human Vaccine Institute at Duke University School of Medicine, believe they have found a way to tip the odds in the immune system's favor.

From the moment of infection, the immune system goes on alert and immediately generates antibodies designed to attach to and destroy HIV. And for the first few weeks, these antibodies are successful, eliminating all but a few viruses that remain hidden away from the body's surveillance systems.

These viral stalwarts then mutate to escape detection and start to flourish, expanding until new antibodies are generated to dispatch them. That launches another wave of viral destruction that pushes HIV to mutate yet again, prompting another immune attack, and so on, until eventually the body isn't able to keep up with the virus and pushes out poor, or no more additional antibodies that can neutralize HIV.

That's the scenario in about 80% of those who are infected with HIV. But in a fortunate 20%, this arms race is stacked in the host's favor, with antibodies that are able to neutralize not just the latest, specific mutated version of HIV but a broader range of viral marauders.

Such broadly neutralizing antibodies are the holy grail of AIDS vaccine researchers, who hope to corral these agents in an immunization that can protect against infection.

But by carefully mapping the different mutations that HIV generates, and the resulting antibodies made against them in an African patient who is able to produce broadly neutralizing antibodies, Haynes and his colleagues believe they have come up with a way to drive the immune system to preferentially churn out these HIV-fighting immune cells.

"We followed individuals from the time of HIV infection to the time they generated broadly neutralizing antibodies, and mapped and isolated the virus at every step along the way so we now don't have to guess any more about what induced those antibodies," he says. "We have a map on how to recreate the sequential (versions of HIV) that could drive particular antibody lineages."

The work, which was published in the journal Nature, was possible because Haynes had collected and saved blood samples over the course of about three years from roughly 400 patients, starting within weeks of their infection.

Researchers found that the first round of broadly neutralizing antibodies generally appeared about 14 weeks after infection, and these were better able to bind to portions of HIV that the virus doesn't change as quickly or as frequently. That makes the antibodies useful weapons in attacking the virus' Achilles heel, and a potentially powerful target for an effective vaccine.

full story

Link to comment
Share on other sites

They are making rapid progress in this field. I never thought they would find a breakthrough this fast. I felt like they would they big breakthrough in cancer before AIDS.

Link to comment
Share on other sites

They are making rapid progress in this field. I never thought they would find a breakthrough this fast. I felt like they would they big breakthrough in cancer before AIDS.

^ Cancer cures were found many decades ago, but were suppressed.

I have to agree with Hum on this. I am sure they are much better cures than they use now, but for sake of getting money (hey, they make a lot on donations), and because cancer is one equalizer in the world (that and they don't know any direct 100% pure cause of cancer) they don't want to let loose ways of truly curing cancer as it would take away a lot of jobs, money, and a lot more.

Link to comment
Share on other sites

This topic is now closed to further replies.